Cargando…

A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational study

BACKGROUND: Symptom burden, medical comorbidities, and functional well-being of patients with chronic hepatitis C virus (HCV) initiating direct acting antiviral (DAA) therapy in real-world clinical settings are not known. We characterized these patient-reported outcomes (PROs) among HCV-infected pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Evon, Donna M., Stewart, Paul W., Amador, Jipcy, Serper, Marina, Lok, Anna S., Sterling, Richard K., Sarkar, Souvik, Golin, Carol E., Reeve, Bryce B., Nelson, David R., Reau, Nancy, Lim, Joseph K., Reddy, K. Rajender, Di Bisceglie, Adrian M., Fried, Michael W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070182/ https://www.ncbi.nlm.nih.gov/pubmed/30067745 http://dx.doi.org/10.1371/journal.pone.0196908

Ejemplares similares

Development and pilot-testing of a cognitive behavioral coping skills group intervention for patients with chronic hepatitis C
por: Evon, Donna M., et al.
Publicado: (2017)

Novel patient-reported outcomes (PROs) used in a pilot and feasibility study of a Cognitive Behavioral Coping Skills (CBCS) group intervention for patients with chronic hepatitis C
por: Evon, Donna M., et al.
Publicado: (2018)

A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE Study
por: Sulkowski, Mark S., et al.
Publicado: (2021)

Genome-wide capture sequencing to detect hepatitis C virus at the end of antiviral therapy
por: Peng, Peng, et al.
Publicado: (2020)

Considering direct-acting antivirals to cure hepatitis C virus during pregnancy: is this the last treatment frontier?
por: Kushner, Tatyana, et al.
Publicado: (2019)

Hepatitis-Induced Porphyria: Are Direct-Acting Antiviral Agents the Way of the Future?
por: John, Jason J., et al.
Publicado: (2021)

A paradigm for fostering patient-centered research in liver disease: The liver transplant patient-engagement program
por: Lieber, Sarah R., et al.
Publicado: (2023)

The Prevalence and Impact of Hepatic Steatosis on Response to Direct-Acting Antiviral Therapy in HIV–HCV Coinfection
por: Johnson, Leigh P., et al.
Publicado: (2020)

COVID-19 Vaccine Perceptions Among Patients With Chronic Disease in a Large Gastroenterology and Hepatology Practice
por: Serper, Marina, et al.
Publicado: (2021)

HCV Council – critical appraisal of data: recommendations for clinical practice in a rapidly evolving therapeutic landscape
por: Reau, Nancy, et al.
Publicado: (2015)

A local response to COVID-19 for advanced liver disease: Current model of care, challenges and opportunities
por: Serper, Marina, et al.
Publicado: (2020)

Cost-effectiveness of direct-acting antivirals for chronic hepatitis C virus in the United States from a payer perspective
por: Kaplan, David E, et al.
Publicado: (2022)

Impact of comorbidities and treatment burden on general well-being among women’s cancer survivors
por: Anderson, R. T., et al.
Publicado: (2021)

De novo hepatocellular carcinoma occurrence in hepatitis C cirrhotics treated with direct-acting antiviral agents
por: Kuftinec, Gabriela, et al.
Publicado: (2018)

Impact of the Corona Virus Disease 2019 Pandemic on Hepatology Practice and Provider Burnout
por: Russo, Mark W., et al.
Publicado: (2021)

Cancer, Comorbidities, and Health-Related Quality of Life of Older Adults
por: Smith, Ashley Wilder, et al.
Publicado: (2008)

Genistein Has Antiviral Activity against Herpes B Virus and Acts Synergistically with Antiviral Treatments to Reduce Effective Dose
por: LeCher, Julia C., et al.
Publicado: (2019)

Restless leg syndrome a common undiagnosed comorbidity of clinical significance in cirrhosis
por: Rajender, Akash, et al.
Publicado: (2019)

The Effects of Comorbidity on the Benefits and Harms of Treatment for Chronic Disease: A Systematic Review
por: Fried, Terri R., et al.
Publicado: (2014)

The role of psychological safety and learning behavior in the development of effective quality improvement teams in Ghana: an observational study
por: Albritton, Jordan A., et al.
Publicado: (2019)

Treatment Status of Hepatocellular Carcinoma Does Not Influence Rates of Sustained Virologic Response: An HCV‐TARGET Analysis
por: Radhakrishnan, Kavita, et al.
Publicado: (2019)

Prospects for personalizing antiviral therapy for hepatitis C virus with pharmacogenetics
por: Tavis, John E, et al.
Publicado: (2011)

Well-being in major depression and social phobia with and without comorbidity
por: Wersebe, Hanna, et al.
Publicado: (2018)

2204. In HCV-Infected Patients, Internalized Stigma, but not Experienced Stigma, Is Correlated with Psychological State and Health-Related Quality of Life: Baseline Data from the PROP UP Study
por: Gelman, Michael, et al.
Publicado: (2018)

Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET study
por: Welzel, Tania M, et al.
Publicado: (2017)

2496. Hepatitis C Virus Among Inpatients in the Direct-acting Antiviral Era: Prevalence, Linkage to Care, Treatment Disparities, and Comorbidity Burden
por: Forrister, Nicholas, et al.
Publicado: (2023)

Natural killer cells act as rheostats modulating antiviral T cells
por: Waggoner, Stephen N., et al.
Publicado: (2011)

The Journal of Comorbidity affiliates with the Society for Academic Primary Care
por: Smith, Susan M., et al.
Publicado: (2016)

Glecaprevir and pibrentasvir for 12 weeks for hepatitis C virus genotype 1 infection and prior direct‐acting antiviral treatment
por: Poordad, Fred, et al.
Publicado: (2017)

Comorbidity burden at dialysis initiation and mortality: A cohort study
por: Gomez, Alwyn T, et al.
Publicado: (2015)

Higher mortality among lean patients with non-alcoholic fatty liver disease despite fewer metabolic comorbidities
por: Wijarnpreecha, Karn, et al.
Publicado: (2023)

Comorbidity Influences Multiple Aspects of Well-Being of Patients with Ischemic Heart Disease
por: Assari, Shervin, et al.
Publicado: (2013)

Show Me the Meaning of Being Lonely (and Its Effects on Seizure Burden and Comorbidities)
por: Lozano, Lola, et al.
Publicado: (2019)

Vasopressor weaning in sepsis: Debate is being continued!
por: Bhattacharjee, Sulagna, et al.
Publicado: (2023)

Managing HIV/hepatitis C co-infection in the era of direct acting antivirals
por: Rockstroh, Jürgen K, et al.
Publicado: (2013)

HIV/HCV Antiviral Drug Interactions in the Era of Direct-acting Antivirals
por: Rice, Donald P., et al.
Publicado: (2016)

Assessing the Safety of Direct-Acting Antiviral Agents for Hepatitis C
por: McGlynn, Elizabeth A., et al.
Publicado: (2019)

Comorbidity of Physical and Anxiety Symptoms in Adolescent: Functional Impairment, Self-Rated Health and Subjective Well-Being
por: Balázs, Judit, et al.
Publicado: (2018)

Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct‐acting antiviral treatment failure
por: Poordad, Fred, et al.
Publicado: (2018)

Changing Population of Liver Transplant Recipients in the Era of Direct-acting Antiviral Therapy
por: Xie, Chencheng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jcquoonk4siaamdsljlchkfcjh